Lifecore Biomedical Inc Reports $25.3 Million Revenue and $1. ...
Net Loss Widens to $40.1 Million on Debt Derivative Revaluation; Adjusted EBITDA Improves to $4.0 Million Related Stocks: LFCR ,
Net Loss Widens to $40.1 Million on Debt Derivative Revaluation; Adjusted EBITDA Improves to $4.0 Million Related Stocks: LFCR ,